It is a pharma private limited company based in Gujvail, Telangana, India, established in 2020.
2020 | Gujvail, Telangana, India | ActiveAspiro Pharma Specialities Private Limited, a active private limited company, was established on 29 August 2020 in Gujvail, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24299TG2020PTC143320. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹55.00 Cr and a paid-up capital of ₹55.00 Cr.
It upholds a compliant status. Its leadership includes Bhavesh Bansidhar Pujara (Director), Mahesh Ramappa Kamalamma Hassan (Additional Director). Past directors included Bhavesh Bansidhar Pujara, Sudhakar Gangula, Chandra Sekhar Tumuluru. It holds ₹25.00 Cr open charges and ₹25.00 Cr settled loans. Its latest AGM occurred on 24 July 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. S-1, S-6 & S-2B, Survey No. 321 & 284, Biotech Park Phase - Iii,, Karakapatla Vill, Markook Mandal, Siddipet Dist, Gujvail, Telangana, 502281.
U24299TG2020PTC143320
143320
29 August 2020
₹55.00 Cr
₹55.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Aspiro Pharma Specialities Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhavesh Bansidhar Pujara | Director | 13 Nov 2024 | Current |
| Mahesh Ramappa Kamalamma Hassan | Additional Director | 13 Nov 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 23 Jul 2025 | Past |
| Pramod Abcsdd | Managing Director | 13 Nov 2024 | Past |
| Pramod Abcsdd | Additional Director | 23 Jul 2025 | Past |
| Pramod Abcsdd | Director | 13 Nov 2024 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sundhet Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 312.79% increase. The company also saw a substantial improvement in profitability, with a 179.46% increase in profit. The company's net worth Soared by an impressive increase of 45.17%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Aspiro Pharma Specialities had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹250,000,000.00
₹250,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2022 | State Bank Of India | ₹25.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Aspiro Pharma Specialities has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aspiro Pharma Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspiro Pharma Specialities's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aspiro Pharma Specialities Private Limited last Annual general meeting of members was held on 24 Jul 2025 as per latest MCA records. was documented.
A charge registered on 28 Jun 2022 via Charge ID 100593128 with State Bank Of India was fully satisfied on 29 May 2025. was recorded as a recent event.
Progress on Surekha Anandrao Limbure was appointed as a Company Secretary was appointed as a Company Secretary on 25 Apr 2025 & has been associated with this company since 7 months 5 days . was documented.
The activity Aspiro Pharma Specialities Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
Progress on Dakarapu Srinivas was appointed as a Cfo was appointed as a Cfo on 04 Feb 2025 & has been associated with this company since 9 months 24 days . was documented.
Progress on Bhavesh Bansidhar Pujara was appointed as a Director was appointed as a Director on 13 Nov 2024 & has been associated with this company since 1 year 15 days . was documented.
The CIN of Aspiro Pharma Specialities Private Limited is U24299TG2020PTC143320.
Aspiro Pharma Specialities Private Limited is headquartered at Plot No. S-1, S-6 & S-2B, Survey No. 321 & 284, Biotech Park Phase - Iii,, Karakapatla Vill, Markook Mandal, Siddipet Dist, Gujvail, Telangana, 502281.
Aspiro Pharma Specialities Private Limited was incorporated on 29 August 2020.
The current directors of Aspiro Pharma Specialities Private Limited are
The primary industry of Aspiro Pharma Specialities Private Limited is Manufacturing.
Aspiro Pharma Specialities Private Limited is unlisted.
The authorized capital of Aspiro Pharma Specialities Private Limited is ₹55.00 Cr, and the paid-up capital is ₹55.00 Cr.
The compliance status of Aspiro Pharma Specialities Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX